Company intelligence
Chicago Biomedical Consortium
Stimulating scientific collaboration to accelerate biomedical discovery in the Chicago ecosystem.
About Chicago Biomedical Consortium
Since 2006, the Chicago Biomedical Consortium (CBC) has been accelerating the path from academic discovery to patient impact. Backed by the Searle Funds at The Chicago Community Trust, CBC unites Northwestern University, The University of Chicago, and the University of Illinois Chicago to build a connected, translational ecosystem for the life sciences. Our mission has evolved so that, today, we focus on the translation of academic discoveries into investable biopharma innovations. We apply private-sector rigor and patient capital to overcome early-stage barriers, empowering Illinois’ academic innovators with the expertise, resources, and mentorship needed to succeed. By cultivating skilled operators and advancing breakthrough science toward commercialization, we fuel a dynamic, self-sustaining life sciences ecosystem that generates lasting economic growth and health impact across Illinois.
Verified activity
Signals from Chicago Biomedical Consortium
3 published signals
Presence & Recognition
Chicago Biomedical Consortium is hosting the Hall of Iventions for ground-breaking biotech discoveries based in the Midwest.
Reported by Anne Marie Rzepecki
Presence & Recognition
Chicago Biomedical Consortium is hosting the Midwest BioBuilders Summit taking place November 12, 2026, at Willis Tower in Chicago, featuring the Hall of Inventions to showcase academic entrepreneurs and early-stage companies across therapeutics, drug discovery, translational research tools, diagnostics, and medical devices.
Reported by Chicago Biomedical Consortium
Presence & Recognition
Chicago Biomedical Consortium is hosting Dushyant Pathak, Autobahn Labs, Inc., at the Willis Tower in Chicago for the Midwest Bio Builders Summit on November 12, 2026.
Reported by Chicago Biomedical Consortium